These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

874 related items for PubMed ID: 17707782

  • 1. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y, Song S, Liu C, Wang Y, Xian X, He Y, Wang J, Liu F, Sun S.
    Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
    [Abstract] [Full Text] [Related]

  • 2. Augmented induction of CD8+ cytotoxic T-cell response and antitumor effect by DCs pulsed with virus-like particles packaging with CpG.
    Song S, Wang Y, Zhang Y, Wang F, He Y, Ren D, Guo Y, Sun S.
    Cancer Lett; 2007 Oct 18; 256(1):90-100. PubMed ID: 17656012
    [Abstract] [Full Text] [Related]

  • 3. Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier.
    Kong J, Diao Z, Deng X, Zhong H, Yao W, Hu X.
    Oncol Rep; 2007 Jul 18; 18(1):279-85. PubMed ID: 17549380
    [Abstract] [Full Text] [Related]

  • 4. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.
    Kuhöber A, Pudollek HP, Reifenberg K, Chisari FV, Schlicht HJ, Reimann J, Schirmbeck R.
    J Immunol; 1996 May 15; 156(10):3687-95. PubMed ID: 8621903
    [Abstract] [Full Text] [Related]

  • 5. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F, Peterson D, Hughes J, Wirtz R, Milich D.
    J Biotechnol; 1996 Jan 26; 44(1-3):91-6. PubMed ID: 8717391
    [Abstract] [Full Text] [Related]

  • 6. Melanoma vaccine candidates from chimeric hepatitis B core virus-like particles carrying a tumor-associated MAGE-3 epitope.
    Kazaks A, Balmaks R, Voronkova T, Ose V, Pumpens P.
    Biotechnol J; 2008 Nov 26; 3(11):1429-36. PubMed ID: 18956370
    [Abstract] [Full Text] [Related]

  • 7. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG, Kadoshnikov YP, Kalinina TI, Smirnov VD, Wahren B.
    Biochemistry (Mosc); 1998 May 26; 63(5):551-8. PubMed ID: 9632891
    [Abstract] [Full Text] [Related]

  • 8. Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).
    Mihailova M, Boos M, Petrovskis I, Ose V, Skrastina D, Fiedler M, Sominskaya I, Ross S, Pumpens P, Roggendorf M, Viazov S.
    Vaccine; 2006 May 15; 24(20):4369-77. PubMed ID: 16574285
    [Abstract] [Full Text] [Related]

  • 9. Recombinant heat shock protein 65 carrying hepatitis B core antigen induces HBcAg-specific CTL response.
    Yang BF, Zhao HL, Xue C, Xiong XH, Zhang W, Yao XQ, Liu ZM.
    Vaccine; 2007 May 30; 25(22):4478-86. PubMed ID: 17467856
    [Abstract] [Full Text] [Related]

  • 10. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
    Li L, Tian YJ, Shen H, Zhao XP, Yang DL.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr 30; 17(4):275-9. PubMed ID: 19403026
    [Abstract] [Full Text] [Related]

  • 11. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R.
    Virology; 1997 Aug 18; 235(1):26-39. PubMed ID: 9300034
    [Abstract] [Full Text] [Related]

  • 12. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.
    Huang Z, Santi L, LePore K, Kilbourne J, Arntzen CJ, Mason HS.
    Vaccine; 2006 Mar 24; 24(14):2506-13. PubMed ID: 16417953
    [Abstract] [Full Text] [Related]

  • 13. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I, Alper R, Klein A, Rabbani E, Engelhardt D, Ilan Y.
    Cancer; 2002 Jan 15; 94(2):406-14. PubMed ID: 11900226
    [Abstract] [Full Text] [Related]

  • 14. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus.
    Zhang YL, Guo YJ, Wang KY, Lu K, Li K, Zhu Y, Sun SH.
    Scand J Immunol; 2007 Apr 15; 65(4):320-8. PubMed ID: 17386022
    [Abstract] [Full Text] [Related]

  • 15. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
    Shiau AL, Murray K.
    J Med Virol; 1997 Mar 15; 51(3):159-66. PubMed ID: 9139078
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S, Sroller V, Kunke D, Krystofová J, Kutinová L.
    Acta Virol; 1996 Mar 15; 40(5-6):273-9. PubMed ID: 9171455
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
    Shimizu Y, Guidotti LG, Fowler P, Chisari FV.
    J Immunol; 1998 Nov 01; 161(9):4520-9. PubMed ID: 9794377
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.